The research aims to assess the effectiveness of PRAME and H3K27me3 in distinguishing malignant melanoma from proliferative nodules in congenital melanocytic nevi.
Assessment of PRAME and H3K27me3 expression levels in samples
Comparison of findings between malignant melanoma and proliferative nodules
Analysis of potential diagnostic utility based on initial results
PRAME and H3K27me3 showed promise in differentiating malignant melanoma from proliferative nodules.
Combination of both markers may enhance diagnostic accuracy.
Further validation is needed on larger sample sizes to confirm findings.
Abstract
Combined use of PRAME and H3K27me3 can be utilized to discriminate MM from PN arising in LCMN/GCMN if validated on larger cohorts.